Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
about
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical studyEnhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.Nucleo-cytoplasmic transport as a therapeutic target of cancerKPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice.RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells.The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma.Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models.The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activity.XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).Investigational serine/threonine kinase inhibitors against prostate cancer metastases.RAD51 regulates CHK1 stability via autophagy to promote cell growth in esophageal squamous carcinoma cells.Role of autophagy in regulating the radiosensitivity of tumor cells.Mammalian Target of Rapamycin Inhibition With Rapamycin Mitigates Radiation-Induced Pulmonary Fibrosis in a Murine Model.Advances in prostate cancer research and treatment.Molecularly targeted radiosensitization chances towards gene aberration-due organ confined/regionally advanced prostate cancer radioresistance.UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice.
P2860
Q33712267-3FA08A79-9D3D-471E-82D1-969786841EC8Q33728180-30438B1F-458D-4516-BF3E-392C318E63E0Q34452108-2EFDD298-DABB-41B6-9347-43C8EC30218BQ35856215-890C9741-5DF3-4DE0-B25A-F668E6FF6AB2Q35910232-F55FDADC-ECE2-47A3-B969-B1A0B6598782Q36939659-A3923527-C4AB-4736-B9D4-534D2E844674Q37200271-4FCA5ED0-5634-402D-BD03-7643C4A1719AQ37567174-9E937467-6A13-4536-8C42-A0A45A8207CCQ38848501-CF7DFA73-CE13-4FB1-89F8-E2F0667B2C90Q38866757-83E3405C-DD83-4477-8847-E860D9E7506CQ38950408-82A6425D-D244-48A2-AA68-4EE52A67FF96Q39021945-61860D0A-244E-4785-8301-8B5BD04CFA60Q39289111-E0B0A889-FB9B-48D4-8324-B63187918FDCQ40102474-205D71F8-4A5E-4A97-9DAF-4B87836BAC25Q40509401-EEA58D86-9238-45D2-B058-BA3D4DEF5B00Q42084382-269FF885-72F9-489B-BD9F-E2AE7A58AA93Q42113453-BDFF82BC-B592-4836-AE6D-7A0162235CF8Q54946129-3A69D468-852F-4FFD-B015-59F11B002040
P2860
Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Torc1/Torc2 inhibitor, Palomid ...... air in prostate cancer models.
@en
Torc1/Torc2 inhibitor, Palomid ...... air in prostate cancer models.
@nl
type
label
Torc1/Torc2 inhibitor, Palomid ...... air in prostate cancer models.
@en
Torc1/Torc2 inhibitor, Palomid ...... air in prostate cancer models.
@nl
prefLabel
Torc1/Torc2 inhibitor, Palomid ...... air in prostate cancer models.
@en
Torc1/Torc2 inhibitor, Palomid ...... air in prostate cancer models.
@nl
P2093
P2860
P50
P356
P1433
P1476
Torc1/Torc2 inhibitor, Palomid ...... air in prostate cancer models.
@en
P2093
Claudio Festuccia
David Sherris
Ernesto Di Cesare
Francesca Vittorini
Vincenzo Tombolini
P2860
P304
P356
10.1002/PROS.22804
P577
2014-04-08T00:00:00Z